Tag: BRCA1 or BRCA2 mutations

NICE rejects use of prostate cancer drug olaparib

Pri Mandav - January 5, 2022

The National Institute for Health and Care Excellence (NICE) has rejected the use of olaparib on the NHS for treatment of adults with hormone-relapsed...

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Omnicell appoints new community pharmacy division leader

News November 29, 2023 0

Dedicated specialist teams developed to better deliver on the...

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

News November 29, 2023 0

Cancer Research UK has estimated that half a million...

NHS capital budgets need to nearly double to enable 21st century patient care

News November 29, 2023 0

Greater funding is required if the NHS is to...

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW March 24, 2023 0

After two days of intense deliberation on the future...

Pharmacy Business Diversity Conference – session summary: ‘Building environment of trust and comfort is must to tackle mental health issues at workplace’

Conference December 17, 2021 0

Mental health has become a major concern worldwide and...

ITV invests in pain relief brand Flarin

News August 16, 2023 0

ITV on Tuesday (Aug 15) said it had agreed...

Omnicell appoints new community pharmacy division leader

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

NHS capital budgets need to nearly double to enable 21st century patient care

MHRA increases scrutiny of valproate prescribing to protect patients from its side effects

Subscription Plans

Free limited access

Member full access

Omnicell appoints new community pharmacy division leader

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

NHS capital budgets need to nearly double to enable 21st century patient care

MHRA increases scrutiny of valproate prescribing to protect patients from its side effects

Tag: BRCA1 or BRCA2 mutations

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

NHS capital budgets need to nearly double to enable 21st century patient care

MHRA increases scrutiny of valproate prescribing to protect patients from its side effects

UK extends partnership with FIND to combat antimicrobial resistance

Government proposes pay reform deal to consultants to halt strikes

Follow us

Company

Latest news

Omnicell appoints new community pharmacy division leader

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

NHS capital budgets need to nearly double to enable 21st century patient care

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

Pharmacy Business Diversity Conference – session summary: ‘Building environment of trust and comfort is must to tackle mental health issues at workplace’

ITV invests in pain relief brand Flarin

Pharmacy Business